Therapeutic drug monitoring of amikacin in septic patients

Article English OPEN
Duszynska, Wieslawa; Taccone, Fabio; Hurkacz, Magdalena; Kowalska-Krochmal, Beata; Wiela-Hojeńska, Anna; Kübler, Andrzej;

Introduction Use of higher than standard doses of amikacin (AMK) has been proposed during sepsis, especially to treat less susceptible bacterial strains. However, few data are available on drug concentrations during prolonged therapy and on potential adverse events rela... View more
  • References (33)
    33 references, page 1 of 4

    1. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Lebovici L: Beta lactam antibiotic monotherapy versus beta lactam-aminoglicoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2006, CD003344.

    2. Basseti M Righi E, Esposito S, Petrosillo N, Nicolini L: Drug treatment for multidrug-resistant Acinetobacter baumanii infections. Future Microbiol 2008, 3:649-660.

    3. Hirsch EB, Tam VH: Detection and treatment options for Klebsiella pneumonia carbapenemases (KPCs): an emerging cause of multidrugresistant infection. J Antimicrob Chemother 2010, 65:1119-1125.

    4. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.

    5. Safdar N, Handelsman J, Maki DG: Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A metaanalysis. Lancet Infect Dis 2004, 4:519-527.

    6. Kumar A, Safdar N, Kethireddy S, Chateau D: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a metaanalytic/meta-regression study. Crit Care Med 2010, 38:1651-1664.

    7. Craig WA: Optimizing aminoglicoside use. Crit Care Clin 2011, 27:107-121.

    8. Roberts J, Lipman J: Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 2006, 45:755-773.

    9. Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H: Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 2008, 30:674-681.

    10. Roberts JA, Lipman J: Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009, 37:840-851.

  • Similar Research Results (3)
  • Related Organizations (2)
  • Metrics
Share - Bookmark